148 related articles for article (PubMed ID: 19033810)
1. Tumoral calcinosis demonstrated on Tc-99m sestamibi scintigraphy.
Chang CY; Cheng CY; Shen DH; Bai CY; Lin LF; Huang WS
Clin Nucl Med; 2008 Dec; 33(12):920-1. PubMed ID: 19033810
[TBL] [Abstract][Full Text] [Related]
2. Technetium-99m-sestamibi scintigraphy in multiple myeloma and related gammopathies: a useful tool for the identification and follow-up of myeloma bone disease.
Balleari E; Villa G; Garrè S; Ghirlanda P; Agnese G; Carletto M; Clavio M; Ferrando F; Gobbi M; Mariani G; Ghio R
Haematologica; 2001 Jan; 86(1):78-84. PubMed ID: 11146575
[TBL] [Abstract][Full Text] [Related]
3. Use of technetium Tc 99m sestamibi scintigraphy for recurrent tertiary hyperparathyroidism from a parathyroid forearm graft.
Chen H; Civelek AC; Westra WH; Scheel PJ; Udelsman R
South Med J; 2000 Feb; 93(2):215-7. PubMed ID: 10701792
[TBL] [Abstract][Full Text] [Related]
4. Secondary hyperparathyroidism: detection with I-123-Tc-99m-Sestamibi subtraction scintigraphy versus US.
Jeanguillaume C; Ureña P; Hindié E; Prieur P; Pétrover M; Menoyo-Calonge V; Janin A; Chiappini-Briffa D; Mellière D; Boulahdour H; Galle P
Radiology; 1998 Apr; 207(1):207-13. PubMed ID: 9580138
[TBL] [Abstract][Full Text] [Related]
5. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
Lind P; Gallowitsch HJ
Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
[TBL] [Abstract][Full Text] [Related]
6. The role of bone scanning in the detection of metastatic calcification: a case report.
Nizami MA; Gerntholtz T; Swanepoel CR
Clin Nucl Med; 2000 Jun; 25(6):407-9. PubMed ID: 10836684
[TBL] [Abstract][Full Text] [Related]
7. Extraosseous Tc-99m MDP uptake: a pathophysiologic approach.
Peller PJ; Ho VB; Kransdorf MJ
Radiographics; 1993 Jul; 13(4):715-34. PubMed ID: 8356264
[TBL] [Abstract][Full Text] [Related]
8. Radiography and scintigraphy in tumoral calcinosis.
Brown ML; Thrall JH; Cooper RA; Kim YC
Radiology; 1977 Sep; 124(3):757-8. PubMed ID: 196314
[TBL] [Abstract][Full Text] [Related]
9. Preoperative technetium Tc 99m sestamibi SPECT imaging in the management of primary hyperparathyroidism in patients with concomitant multinodular goiter.
Lorberboym M; Ezri T; Schachter PP
Arch Surg; 2005 Jul; 140(7):656-60. PubMed ID: 16027330
[TBL] [Abstract][Full Text] [Related]
10. Primary osteogenic sarcoma of breast detected on Tc-99m MIBI scintigraphy and Tc-99m MDP skeletal scintigraphy.
Yang JG; Li CL; Hao RR; Zou LF
Ann Nucl Med; 2008 Jan; 22(1):79-82. PubMed ID: 18250991
[TBL] [Abstract][Full Text] [Related]
11. Antecedent 99mTc-MDP and 99mTc-sestamibi administration corrupts bone mineral density measured by DXA.
McKiernan FE; Hocking J; Cournoyer S
J Clin Densitom; 2006; 9(2):164-6. PubMed ID: 16785076
[TBL] [Abstract][Full Text] [Related]
12. Preoperative localization of parathyroid tissue with technetium-99m sestamibi 123I subtraction scanning.
Thulé P; Thakore K; Vansant J; McGarity W; Weber C; Phillips LS
J Clin Endocrinol Metab; 1994 Jan; 78(1):77-82. PubMed ID: 8288719
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of 99mTc-sestamibi scintigraphy for healing of extremity amputation.
Sarikaya A; Top H; Aygit AC; Benlier E; Unal Y
Eur J Nucl Med Mol Imaging; 2006 Dec; 33(12):1500-7. PubMed ID: 16896671
[TBL] [Abstract][Full Text] [Related]
14. Technetium-99m-sestamibi single agent localization versus high resolution ultrasonography for the preoperative localization of parathyroid glands in patients with primary hyperparathyroidism.
Billy HT; Rimkus DR; Hartzman S; Latimer RG
Am Surg; 1995 Oct; 61(10):882-8. PubMed ID: 7668462
[TBL] [Abstract][Full Text] [Related]
15. Potential false positive Tc-99m sestamibi parathyroid study due to uptake in brown adipose tissue.
Wong KK; Brown RK; Avram AM
Clin Nucl Med; 2008 May; 33(5):346-8. PubMed ID: 18431153
[TBL] [Abstract][Full Text] [Related]
16. Radioguided surgery of primary hyperparathyroidism using the low-dose 99mTc-sestamibi protocol: multiinstitutional experience from the Italian Study Group on Radioguided Surgery and Immunoscintigraphy (GISCRIS).
Rubello D; Pelizzo MR; Boni G; Schiavo R; Vaggelli L; Villa G; Sandrucci S; Piotto A; Manca G; Marini P; Mariani G
J Nucl Med; 2005 Feb; 46(2):220-6. PubMed ID: 15695779
[TBL] [Abstract][Full Text] [Related]
17. Limited sensitivity of parathyroid imaging with (99m)Tc-sestamibi/(123)I subtraction in an endemic goiter area.
Rink T; Schroth HJ; Holle LH; Garth H
J Nucl Med; 2002 Sep; 43(9):1175-80. PubMed ID: 12215555
[TBL] [Abstract][Full Text] [Related]
18. Tc-99m sestamibi thyroid imaging in patients on chronic amiodarone treatment: a comparison with Tc-99m pertechnetate imaging.
Oki GC; Zantut-Wittmann DE; de Oliveira Santos A; Guariento MH; Tambascia MA; de Almeida EA; Amorim BJ; Lima MC; Etchebehere EC; Camargo EE; Ramos CD
Clin Nucl Med; 2010 Apr; 35(4):223-7. PubMed ID: 20305407
[TBL] [Abstract][Full Text] [Related]
19. Predicting the effect of intravenous calcitriol on parathyroid gland activity using double-phase technetium Tc 99m-sestamibi scintigraphy.
Torregrosa JV; Fuster D; Ybarra J; Ortín J; Moreno A; Valveny N
Am J Kidney Dis; 2004 Sep; 44(3):476-80. PubMed ID: 15332220
[TBL] [Abstract][Full Text] [Related]
20. Relation between technetium 99m-methoxyisobutylisonitrile accumulation and multidrug resistance protein in the parathyroid glands.
Yamaguchi S; Yachiku S; Hashimoto H; Kaneko S; Nishihara M; Niibori D; Shuke N; Aburano T
World J Surg; 2002 Jan; 26(1):29-34. PubMed ID: 11898030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
